Company news
Changchun BCHT Biotechnology Co. news in 2026
Changchun BCHT Biotechnology Co.'s news releases, calls and decks from 2026, newest first.
(688276)"Changchun Bcht Biotechnology Co."Report for Q3 2026
October 29, 2026
(688276)"Changchun Bcht Biotechnology Co."Announcement on Provision for Asset Impairment for the First Three Quarters of 2026
October 29, 2026
(688276)"Changchun Bcht Biotechnology Co."Announcement on Notifying Creditors of Merger by Absorption of Wholly-owned Subsidiary
October 29, 2026
(688276)"Changchun Bcht Biotechnology Co."Announcement on Merger by Absorption of the Wholly-owned Subsidiary Jilin Huikang Biopharmaceutical Co., Ltd.
October 29, 2026
(688276)"Changchun Bcht Biotechnology Co."Announcement on Convening the Q3 2026 Performance Briefing
October 21, 2026
Announcement on Voluntary Disclosure Regarding the Acceptance of the Clinical Trial Application for the Combination Formulation of Recombinant Human Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibody Injection
September 22, 2026
Semi-annual Report for 2026
August 20, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 12, 2026
Announcement on Return of Previously Used Funds Raised for Temporary Working Capital Supplement and Use of a Portion of Idle Funds Raised for Temporary Working Capital Supplement
June 30, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 15, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Jilin Jurisdiction
May 11, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 30, 2026
Notice on Convening the 2025 Annual General Meeting
April 21, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
April 13, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Expected Loss in Performance for 2025
January 16, 2026